Editor-in-Chief: Kailash C. Gupta, Division of AIDS, NIAID, NIH
AIDS Research and Therapy is an open access, peer reviewed journal publishing basic science and clinically important research articles to help abate the spread of AIDS.
The journal is edited by Kailash C. Gupta with the assistance of an expert Editorial Board, including Deputy Editor Greg T. Spear, and Section Editors Edward A. Berger (Basic Science), Genoveffa Franchini (Vaccines), Magnus Gisslen (Neuro-AIDS), Richard Koup (Therapeutics), and John J. Rossi (Novel treatment strategies).
Submit your manuscript online.
Latest articles
Research
Adherence to anti-retroviral therapy among HIV patients in Bangalore, India
M B Cauldbeck, C O'Connor, M B O'Connor, J A Saunders, B Rao, G V Mallesh, K N Praveenkumar, D Mamtha, C McGoldrick, Rbs Laing, K S Satish
AIDS Research and Therapy 2009, 6:7 (28 April 2009)
[Abstract] [Provisional PDF] [PubMed] [Related articles]
|
|
Review
Ankle-brachial index in HIV infection
Julián Olalla, Daniel Salas, Javier de la Torre, Alfonso del Arco, José Luis Prada, Francisco Martos, Emilio Perea-Milla, Javier García-Alegría
AIDS Research and Therapy 2009, 6:6 (27 April 2009)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]
|
|
Research
Comparative study of the persistence of anti-HIV activity of deoxynucleoside HIV reverse transcriptase inhibitors after removal from culture
Elijah Paintsil, Susan P Grill, Ginger E Dutschman, Yung-Chi Cheng
AIDS Research and Therapy 2009, 6:5 (22 April 2009)
[Abstract] [Provisional PDF] [PubMed] [Related articles]
|
|
Hypothesis
Is vitamin D deficiency involved in the immune reconstitution inflammatory syndrome?
Anali Conesa-Botella, Chantal Mathieu, Robert Colebunders, Rodrigo Moreno-Reyes, Evelyne van Etten, Lut Lynen, Luc Kestens
AIDS Research and Therapy 2009, 6:4 (21 April 2009)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]
|
|
Research
A randomized, controlled trial of initial anti-retroviral therapy with abacavir/lamivudine/zidovudine twice-daily compared to atazanavir once-daily with lamivudine/zidovudine twice-daily in HIV-infected patients over 48 weeks (ESS100327, the ACTION Study)
Princy N Kumar, Patricia Salvato, Anthony LaMarca, Edwin DeJesus, Parul Patel, Daniel McClernon, Allison Florance, Mark S Shaefer
AIDS Research and Therapy 2009, 6:3 (9 April 2009)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]
|
|
|
|
